Dual effects of vitamin D-induced alteration of TH1/T H2 cytokine expression: Enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease

Journal of Allergy and Clinical Immunology

Volumn 112, Issue 3, 2003, Pages 585-592

  Matheu, Victor ^a   Bäck, Ove ^a   Mondoc, Emma ^a   Issazadeh Navikas, Shohreh ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Allergy; Costimulation; Cytokines; Eosinophils; IL 13; IL 4; IL 5; Inflammation; Knockout; Lung; Vitamin D

Indexed keywords

CALCITRIOL; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; LOEFFLER PNEUMONIA; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TREATMENT OUTCOME;

ALLERGENS; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; EOSINOPHILIA; FEMALE; HYPERSENSITIVITY; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-4; LUNG; MICE; MICE, KNOCKOUT; OVALBUMIN; TH1 CELLS; TH2 CELLS; TIME FACTORS; VITAMIN D;

EID: 0043237446     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(03)01855-4     Document Type: Article

References (49)

1. Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxy-vitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000;374:334-8.
2. Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 1985;134:3032-5.
3. Iho S, Kura F, Sugiyama H, Takahashi T, Hoshino T. The role of monocytes in the suppression of PHA-induced proliferation and IL 2 production of human mononuclear cells by 1,25-dihydroxyvitamin D3. Immunol Lett 1985;11:331-6.
4. Reichel H, Koeffler HP, Tobler A, Norman AW. 1 alpha, 25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci U S A 1987;84:3385-9.
5. Mathieu C, Bouillon R, Rutgeerts O, Vandeputte M, Waer M. Potential role of 1,25(OH)2 vitamin D3 as a dose-reducing agent for cyclosporine and FK 506. Transplant Proc 1994;26:3130.
6. Lemire JM, Adams JS, Sakai R, Jordan SC. 1 alpha, 25-dihydroxy-vitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 1984;74:657-61.
7. Yang S, Smith C, DeLuca HF. 1 alpha, 25-Dihydroxyvitamin D3 and 19-nor-1 alpha, 25-dihydroxyvitamin D2 suppress immunoglobulin production and thymic lymphocyte proliferation in vivo. Biochim Biophys Acta 1993;1158:279-86.
8. Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th 1 functions. J Nutr 1995;125:1704S-8S.
9. Lemire JM, Archer DC. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of routine experimental autoimmune encephalomyelitis. J Clin Invest 1991:87:1103-7.
10. Lemire JM, Adams JS. 1,25-Dihydroxyvitamin D3 inhibits the passive transfer of cellular immunity by a myelin basic protein-specific T cell clone. J Bone Miner Res 1992;7:171-7.
11. Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxyvitamin D3 reversibly bocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A 1996:93:7861-4.
12. Mattner F, Smiroldo S, Galbiati F, Muller M, Di Lucia P, Poliani PL, et al. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1.25-dihydroxyvitamin D(3). Eur J Immunol 2000;30:498-508.
13. Mathieu C, Laureys J, Sobis H, Vandeputte M, Waer M, Bouillon R. 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes 1992;41:1491-5.
14. Casteels KM, Mathieu C, Waer M, Valckx D, Overbergh L, Laureys JM, et al. Prevention of type 1 diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A. Endocrinology 1998;139:95-102.
15. Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in routine models of human arthritis. J Nutr 1998;128:68-72.
16. Cantorna MT, Hullett DA, Redaelli C, Brandt CR, Humpal-Winter J, Sollinger HW, et al. 1,25-Dihydroxyvitamin D3 prolongs graft survival without compromising host resistance to infection or bone mineral density. Transplantation 1998;66:828-31.
17. Overbergh L, Decallonne B, Waer M, Rutgeerts O, Valckx D, Casteels KM, et al. 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GA D65 (p524-543). Diabetes 2000;49:1301-7.
18. Cantorna MT, Woodward WD, Hayes CE, DeLuca HF. 1,25-dihydroxyvitamin D3 is a positive regulator for the two anti- encephalitogenic cytokines TGF-beta 1 and IL-4. J Immunol 1998:160:5314-9.
19. Holgate ST. The epidemic of allergy and asthma. Nature 1999;402:B2-4.
20. Priftanji A, Strachan D, Burr M, Sinamati J, Shkurti A, Grabocka E, et al. Asthma and allergy in Albania and the UK. Lancet 2001;358:1426-7.
21. Steerenberg PA, Van Amsterdam JG, Vandebriel RJ, Vos JG, Van Bree L, Van Loveren H. Environmental and lifestyle factors may act in concert to increase the prevalence of respiratory allergy including asthma. Clin Exp Allergy 1999;29:1303-8.
22. Matricardi PM. Prevalence of atopy and asthma in eastern versus western Europe: why the difference? Ann Allergy Asthma Immunol 2001;87:24-7.
23. Hijazi N, Abalkhail B, Seaton A. Diet and childhood asthma in a society in transition: a study in urban and rural Saudi Arabia. Thorax 2000;55:775-9.
24. Matheu V, Navikas V, Issazadeh S. Susceptibility of B10.R111 mouse strain to develop inflammatory allergic pulmonary disease. Alergol Immunol Clin 2001;16:282-90.
25. Smith EA, Frankenburg EP, Goldstein SA, Koshizuka K, Elstner E, Said J, et al. Effects of long-term administration of vitamin D3 analogs to mice. J Endocrinol 2000;165:163-72.
26. Jirapongsananuruk O, Melamed I, Leung DY. Additive immunosuppressive effects of 1,25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responses. J Allergy Clin Immunol 2001;106:981-5.
27. Jabara HH, Brodeur SR, Geha RS. Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching. J Clin Invest 2001;107:371-8.
28. Brusselle GG, Kips JC, Tavernier JH, van der Heyden JG, Cuvelier CA, Pauwels RA, et al. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 1994;24:73-80.
29. Casteels K, Waer M, Laureys J, Valckx D, Depovere J, Bouillon R, et al. Prevention of antoimmune destruction of syngenic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine. Transplantation 1998;65:1225-32.
30. D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, et al. Inhibition of 1L-12 production by 1,25-dihydroxyvitamin D3. J Clin Invest 1998;101:252-62.
31. Cantorna MT, Humpal-Winter J, DeLuca HF. In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D(3). Arch Biochem Biophys 2000;377:135-8.
32. Pakkala S, de Vos S, Elstner E, Rude RK, Uskokovic M, Binderup L, et al. Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels. Leuk Res 1995;19:65-72.
33. Zhou JY, Norman AW, Chen DL, Sun GW, Uskokovic M, Koeffler HP. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice. Proc Natl Acad Sci U S A 1990;87:3929-32.
34. Meehan TF, DeLuca HF. CD8(+) T cells are not necessary for 1 alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. Proc Natl Acad Sci U S A 2002;99:5557-60.
35. Adorini L, Penna G, Casorati M, Davalli AM, Gregori S. Induction of transplantation tolerance by 1,25-dihydroxyvitamin D(3). Transplant Proc 2001;33:58-9.
36. Cantorna MT, Munsick C, Bemiss C, Mahon BD.1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 2000;130:2648-52.
37. Mori A, Kaminuma O, Mikami T, Inoue S, Okumura Y, Akiyama K, et al. Transcriptional control of the IL-5 gene by human helper T cells: IL-5 synthesis is regulated independently from IL-2 or IL-4 synthesis. J Allergy Clin Immunol 1999:S429-36.
38. Zhang DH, Yang L, Ray A. Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3. J Immunol 1998;161:3817-21.
39. Morawetz RA, Gabriele L, Rizzo LV, Noben-Trauth N, Kuhn R, Rajewsky K, et al. Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (1g)E in the mouse. J Exp Med 1996;184:1651-61.
40. Ferlin WG, Severinson E, Strom L, Heath AW, Coffman RL, Ferrick DA, et al. CD40 signaling induces interleukin-4-independent IgE switching in vivo. Eur J Immunol 1996;26:2911-5.
41. Sullivan S, Broide DH. Compartmentalization of eosinophil granulocyte-macrophage colony-stimulating factor expression in patients with asthma. J Allergy Clin Immunol 1996;97:966-76.
42. Wang J, Palmer K, Lotvall J, Milan S, Lei XF, Matthaei KI, et al. Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia. J Clin Invest 1998;102:1132-41.
43. Gulbenkian AR, Egan RW, Fernandez X, Jones H, Kreutner W, Kung T, et al. Interlukin-5 modulates eosinophil accumaulation in alergic guinea pig lung. Am Rev Respir Dis 1992;146:263-6.
44. Mauser PJ, Pitman A, Witt A, Fernandez X, Zurcher J, Kung T, et al. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis 1993;148:1623-7.
45. Martin LB, Kita H, Leiferman KM, Gleich GH. Eosinophils in allergy: role in disease, degranulation, and cytokines. Int Arch Allergy Immunol 1996;109:207-15.
46. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
47. Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M, Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000;161:9-16.
48. Obase Y, Shimoda T, Mitsuta K, Matsuo N, Matsuse H, Kohno S. Correlation between airway hyperresponsiveness and airway inflammation in a young adult population: cosinophil, ECP, and cytokine levels in induced sputum. Ann Allergy Asthma Immunol 2001;86:304-10.
49. Gijbels MJ, Elliott GR, HogenEsch H, Zurcher C, van den Hoven A, Bruijnzeel PL. Therapeutic interventions in mice with chronic proliferative dermatitis (cpdm/cpdm). Exp Dermatol 2000;9:351-8.